Last updated: 2026-09-16 09:45:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
LeMaitre Vascular, Inc. (LMAT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $79,56, with a market capitalisation of $1,85B and a P/E ratio of 27,94. Over the past 52 weeks, its price has ranged from $78,27 to $118,01. This page covers its latest market performance, valuation, price trends and company information.
$1,85B | |
$80,34 | |
$118,01 | |
$1,54 | |
$80,24 | |
1,01K | |
362,28K | |
27,94 | |
$118,01 | |
$78,27 | |
1,12% | |
-- |
LeMaitre Vascular, Inc. (LMAT) is trading at $79,56 in pre-market trading as of 2026-09-16 08:36:00, down 0,85% ($0,68) from the previous close of $80,24
Pre-market trading shows how investors are pricing LMAT before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, LeMaitre Vascular, Inc. (LMAT) moved from $80,67 to $79,56, representing a decline of 1,38% ($1,11).
The stock traded between $78,29 and $81,82 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 259,99 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 3,2%
LMAT is currently trading at $79,56, placing it 3,2% of the way from its 52-week low of $78,27 to its 52-week high of $118,01. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 655 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of LeMaitre Vascular, Inc. (LMAT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.